期刊文献+

人乳头瘤病毒基因分型检测及意义

暂未订购
导出
摘要 宫颈癌是目前常见的妇科恶性肿瘤之一。据全球范围统计,在所有妇科恶性肿瘤中宫颈癌占10%,每年有471,000例新发病例以及215,000例死亡病例。随着人们对宫颈癌病因学的研究发展,WHO于1992年宣布HPV是引起宫颈癌变的首要因素。依据与宫颈癌的关系,将HPV分为高危型和低危型,高危型包括:HPV16、18、31、33、35、39、45、51、52、56、58、66、69等型;低危型包括:6、11、43、44等型。在HPV疫苗尚未在人群中应用之前.筛查仍是预防和控制宫颈癌的主要手段。
作者 李卓园
出处 《海南医学》 CAS 2007年第11期177-178,共2页 Hainan Medical Journal
  • 相关文献

参考文献15

  • 1Parkin DM,Bray F,Ferlay,et al.Estimating the World carcer burder.Global Cancer,2000.Int J Carcer,2001,94:153.
  • 2Cuzic KJ,Terry G,Ho-L,et al.Association between high-risk HPV types,HLA DRB1* and DQB1* alleles and cervical cancer in British women[J].Br J Cancer,2000,82(7):1348-1352.
  • 3赵方辉,乔友林.宫颈癌病因学研究进展[J].癌症进展,2004,2(1):39-42. 被引量:22
  • 4Ethel-Michele de Vilhers.Papillomavirus and HPV typing.Biochim Biophys Acta,1997,15:199-206.
  • 5Bosch FX,Lorincz A,Munoz N.et al.the causal relation between human papillomavirus and cervical carcer.J Chin pathol,2002,55,244-265.
  • 6Oh TJ.Kim CJ,Woo SK et al,Development and clinical evaluatin of a highly sensitive DNA microarray for detectin and genotyping of human papillomaviruses.J Clin Microbiol,2004,42(7):3272-3280.
  • 7Saiki PK,Walsh PS.Levenson CH et al.Genetic analysis of amplified DNA with immobized Seqense-apecific olisonllcltide probes.PIoc Natl Acad sci USA,1989,86:6230-6234.
  • 8Klaassen CH.Prinsen CF,de Valk HA.Et al.NDA Microartays formal for detectin and subtyping of human papllomavirus.J Chip Microbiol,2004,42(5):2152-2160.
  • 9Park TC.Kim CJ.Koh YM.et al.human papllomavirus genotyping by the DNA chip in the cer vical neoplasia.DNA Cell Boil,2004,23(2):119-115.
  • 10An HJ,Cho NH,Lee SY,et al.Correlation of cervical carcinoma and precancerous lesions with human papillomavirus(HPV)genotypes detected with the HPV DNA chip microarray methods,Cancer,2003,97(7):1672-1680.

二级参考文献33

  • 1谭兵兵 李昆 等.人乳头瘤病毒与中国妇女宫颈癌相关性研究Ⅰ·女性生殖道病变组织中人乳头瘤病毒DNA相关序列的检测[J].合肥医学院学报,1989,12(4):1-1.
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:868
  • 3[1]Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer burden:Global cancer 2000.Int J cancer,2001,94:153
  • 4[3]World Health Organization.Cytological screening in the control of cervical cancer:Technical guidelines.Geneva:World Health Organization,1988
  • 5[4]Anttila A,Pukkala E,Soderman B,et al.Effect of organized screening on cervical cancer incidence and mortality in Fiuland,1963~1995:Recent increase in cervical cancer incidence.Int J Cancer,1999,83:59
  • 6[5]Lombard I,Vincent-Salomon A,Validire P,et al.Human papillomavirus genotype as a major determinant of the course of cervical cancer.J Clin Oncol,1998,16:2613
  • 7[6]McLachlin CM.Human papillomavirus in cervical neoplasia:Role,risk factors,and implictions.Clin Lab Med,2000,20(2):257
  • 8[8]Eluf-Neto J,Booth M,Munoz N,et al.Human papillomavirus and invasive cancer in Braizil.Br J Cancer,1994,69:114
  • 9[9]Fuchs PG,Girardi F,Pfister H,et al.Human papillomavirus DNA in normal,metaplastic,preneoplastic and neoplastic epithelia of the cervix uteri.Int JCancer,1988,41:41
  • 10[10]Lorincz AT,Temple GF,Kurman RJ,et al.Oncogenic association of specific human papillomavirus types with cervical neoplasia.J Natl Cancer Inst,1987,79:671

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部